Kayhan Batmanghelich

University of Pennsylvania, Philadelphia, PA, United States

Are you Kayhan Batmanghelich?

Claim your profile

Publications (4)5.94 Total impact

  • [show abstract] [hide abstract]
    ABSTRACT: Connectivity matrices obtained from various modalities (DTI, MEG and fMRI) provide a unique insight into brain processes. Their high dimensionality necessitates the development of methods for population-based statistics, in the face of small sample sizes. In this paper, we present such a method applicable to functional connectivity networks, based on identifying the basis of dominant connectivity components that characterize the patterns of brain pathology and population variation. Projection of individual connectivity matrices into this basis allows for dimensionality reduction, facilitating subsequent statistical analysis. We find dominant components for a collection of connectivity matrices by using the projective non-negative component analysis technique which ensures that the components have non-negative elements and are non-negatively combined to obtain individual subject networks, facilitating interpretation. We demonstrate the feasibility of our novel framework by applying it to simulated connectivity matrices as well as to a clinical study using connectivity matrices derived from resting state magnetoencephalography (MEG) data in a population of subjects diagnosed with autism spectrum disorder (ASD).
    Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention. 01/2012; 15(Pt 3):231-8.
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Magnetic resonance imaging (MRI) patterns were examined together with cerebrospinal fluid (CSF) biomarkers in serial scans of Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with mild cognitive impairment (MCI). The SPARE-AD score, summarizing brain atrophy patterns, was tested as a predictor of short-term conversion to Alzheimer's disease (AD). MCI individuals that converted to AD (MCI-C) had mostly positive baseline SPARE-AD (Spatial Pattern of Abnormalities for Recognition of Early AD) and atrophy in temporal lobe gray matter (GM) and white matter (WM), posterior cingulate/precuneous, and insula. MCI individuals that converted to AD had mostly AD-like baseline CSF biomarkers. MCI nonconverters (MCI-NC) had mixed baseline SPARE-AD and CSF values, suggesting that some MCI-NC subjects may later convert. Those MCI-NC with most negative baseline SPARE-AD scores (normal brain structure) had significantly higher baseline Mini Mental State Examination (MMSE) scores (28.67) than others, and relatively low annual rate of Mini Mental State Examination decrease (-0.25). MCI-NC with midlevel baseline SPARE-AD displayed faster annual rates of SPARE-AD increase (indicating progressing atrophy). SPARE-AD and CSF combination improved prediction over individual values. In summary, both SPARE-AD and CSF biomarkers showed high baseline sensitivity, however, many MCI-NC had abnormal baseline SPARE-AD and CSF biomarkers. Longer follow-up will elucidate the specificity of baseline measurements.
    Neurobiology of aging 12/2011; 32(12):2322.e19-27. · 5.94 Impact Factor
  • Source
    K.N. Batmanghelich, D.H. Ye, K.M. Pohl, B. Taskar, C. Davatzikos
    [show abstract] [hide abstract]
    ABSTRACT: We present a new semi-supervised algorithm for dimensionality reduction which exploits information of unlabeled data in order to improve the accuracy of image-based disease classification based on medical images. We perform dimensionality reduction by adopting the formalism of constrained matrix decomposition of to semi-supervised learning. In addition, we add a new regularization term to the objective function to better captur the affinity between labeled and unlabeled data. We apply our method to a data set consisting of medical scans of subjects classified as Normal Control (CN) and Alzheimer (AD). The unlabeled data are scans of subjects diagnosed with Mild Cognitive Impairment (MCI), which are at high risk to develop AD in the future. We measure the accuracy of our algorithm in classifying scans as AD and NC. In addition, we use the classifier to predict which subjects with MCI will converge to AD and compare those results to the diagnosis given at later follow ups. The experiments highlight that unlabeled data greatly improves the accuracy of our classifier.
    Biomedical Imaging: From Nano to Macro, 2011 IEEE International Symposium on; 05/2011
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Tissue abnormality characterization is a generalized segmentation problem which aims at determining a continu-ous score that can be assigned to the tissue which characterizes the extent of tissue deterioration, with completely healthy tissue being one end of the spectrum and fully abnormal tissue such as lesions, being on the other end. Our method is based on the assumptions that there is some tissue that is neither fully healthy or nor completely abnormal but lies in between the two in terms of abnormality; and that the voxel-wise score of tissue abnormal-ity lies on a spatially and temporally smooth manifold of abnormality. Unlike in a pure classification problem which associates an independent label with each voxel without considering correlation with neighbors, or an absolute clustering problem which does not consider a priori knowledge of tissue type, we assume that diseased and healthy tissue lie on a manifold that encompasses the healthy tissue and diseased tissue, stretching from one to the other. We propose a semi-supervised method for determining such as abnormality manifold, using multi-parametric features incorporated into a support vector machine framework in combination with manifold regularization. We apply the framework towards the characterization of tissue abnormality to brains of multiple sclerosis patients.
    Proc SPIE 01/2008;